Literature DB >> 23992241

More insight into the concept of apathy: a multidisciplinary depression management program has different effects on depressive symptoms and apathy in nursing homes.

Ruslan Leontjevas1, Steven Teerenstra, Martin Smalbrugge, Myrra J F J Vernooij-Dassen, Ernst T Bohlmeijer, Debby L Gerritsen, Raymond T C M Koopmans.   

Abstract

BACKGROUND: Apathy is common in nursing home (NH) residents and it overlaps with depression. This study examines the effects of a multidisciplinary depression program on apathy and depressive motivational and mood symptoms.
METHODS: Secondary analyses of a stepped-wedge cluster-randomized controlled trial were conducted with six measurements. Sixteen dementia NH units and 17 somatic units were enrolled. In the intervention condition, a program containing depression assessment procedures and multidisciplinary treatment (activating strategies, psychotherapy, and medication) was introduced. Usual care was provided in the control condition. Outcomes were assessed using the 10-item Apathy Evaluation Scale and the Cornell Scale for Depression in Dementia.
RESULTS: Intention-to-treat analyses showed that the whole depression management program reduced apathy in dementia units (p < 0.001; Cohen's d, -0.35), and depressive motivational symptoms in somatic units (p = 0.008; Cohen's d, -0.40). Depressive mood symptoms were not affected in both unit types. The effect on apathy in dementia units was mainly attributed to activating strategies (p < 0.001; Cohen's d, -0.73). The effect on motivational symptoms in somatic units was mainly attributed to psychotherapy (p = 0.002; Cohen's d, -0.80). Apathy worsening was associated with pharmacological depression treatment in both unit types (p = 0.009; Cohen's d, 0.35).
CONCLUSIONS: Depression management may affect apathy and depressive symptoms differently, which underpins the position of apathy as a distinct syndrome. NH professionals can effectively use activating strategies in dementia units, and psychotherapy in somatic units. More research is needed on treating depressive mood symptoms, and on effects of antidepressants in NHs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23992241     DOI: 10.1017/S1041610213001440

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  7 in total

Review 1.  Apathy in Dementia: Systematic Review of Recent Evidence on Pharmacological Treatments.

Authors:  Fleur Harrison; Liesbeth Aerts; Henry Brodaty
Journal:  Curr Psychiatry Rep       Date:  2016-11       Impact factor: 5.285

2.  Cortical Thickness of the Salience Network and Change in Apathy Following Antidepressant Treatment for Late-Life Depression.

Authors:  Monique A Pimontel; Nili Solomonov; Lauren Oberlin; Theodora Kanellopoulos; Jennifer N Bress; Matthew J Hoptman; George S Alexopoulos; Faith M Gunning
Journal:  Am J Geriatr Psychiatry       Date:  2020-06-16       Impact factor: 4.105

3.  The Forgotten Psychopathology of Depressed Long-Term Care Facility Residents: A Call for Evidence-Based Practice.

Authors:  Alcina Matos Queirós; Armin von Gunten; Manuela Martins; Nathalie I H Wellens; Henk Verloo
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2021-02-18

4.  Diagnostic criteria for apathy in neurocognitive disorders.

Authors:  David S Miller; Philippe Robert; Larry Ereshefsky; Lawrence Adler; Daniel Bateman; Jeff Cummings; Steven T DeKosky; Corinne E Fischer; Masud Husain; Zahinoor Ismail; Judith Jaeger; Alan J Lerner; Abby Li; Constantine G Lyketsos; Valeria Manera; Jacobo Mintzer; Hans J Moebius; Moyra Mortby; Didier Meulien; Stephane Pollentier; Anton Porsteinsson; Jill Rasmussen; Paul B Rosenberg; Myuri T Ruthirakuhan; Mary Sano; Carla Zucchero Sarracini; Krista L Lanctôt
Journal:  Alzheimers Dement       Date:  2021-05-05       Impact factor: 16.655

5.  Comparison of Functional and Structural Neural Network Features in Older Adults With Depression With vs Without Apathy and Association With Response to Escitalopram: Secondary Analysis of a Nonrandomized Clinical Trial.

Authors:  Lauren E Oberlin; Lindsay W Victoria; Irena Ilieva; Katharine Dunlop; Matthew J Hoptman; Jimmy Avari; George S Alexopoulos; Faith M Gunning
Journal:  JAMA Netw Open       Date:  2022-07-01

Review 6.  Stepped wedge cluster randomised trials: a review of the statistical methodology used and available.

Authors:  D Barker; P McElduff; C D'Este; M J Campbell
Journal:  BMC Med Res Methodol       Date:  2016-06-06       Impact factor: 4.615

Review 7.  Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate.

Authors:  Christopher H van Dyck; Amy F T Arnsten; Prasad R Padala; Olga Brawman-Mintzer; Alan J Lerner; Anton P Porsteinsson; Roberta W Scherer; Allan I Levey; Nathan Herrmann; Nimra Jamil; Jacobo E Mintzer; Krista L Lanctôt; Paul B Rosenberg
Journal:  Am J Geriatr Psychiatry       Date:  2020-05-05       Impact factor: 4.105

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.